TABLE 2.
Part I |
Part II |
|||||
---|---|---|---|---|---|---|
Baseline (n = 96) |
Day 90 (n = 53) |
Day 180 (n = 49) |
||||
Mean | 99% CI | Mean | 99% CI | Mean | 99% CI | |
Quality of life | ||||||
Physical function | 51.32 | 49.00–53.64 | 50.35 | 47.22–53.49 | 50.57 | 47.54–53.60 |
Pain | 61.32 | 57.98–64.66 | 59.35 | 54.65–64.04 | 52.77 | 48.33–57.22 |
Fatigue | 49.11 | 46.80–51.42 | 49.71 | 45.35–54.06 | 48.91 | 44.15–53.67 |
Anxiety | 51.53 | 49.23–53.82 | 54.01 | 48.57–59.45 | 59.93 | 54.11–65.75 |
Depression | 48.68 | 46.70–50.66 | 48.91 | 45.33–52.50 | 49.24 | 45.30–53.17 |
Caregiving burden | 22.65 | 18.76–26.55 | 21.61 | 15.23–27.99 | 20.41 | 13.96–26.85 |
Distress | - | - | 11.81 | 8.17–15.46 | 11.63 | 7.40–15.86 |
Notes: Higher scores indicate more of all variables assessed. Treatment-related distress was not assessed in Part I of the study because CAR T-cell therapy had not yet occurred. Bold numbers indicate statistically significant differences among outcomes over time.